404 related articles for article (PubMed ID: 17565631)
1. How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences?
Amarapurkar DN; Hashimoto E; Lesmana LA; Sollano JD; Chen PJ; Goh KL;
J Gastroenterol Hepatol; 2007 Jun; 22(6):788-93. PubMed ID: 17565631
[TBL] [Abstract][Full Text] [Related]
2. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
[TBL] [Abstract][Full Text] [Related]
3. Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines.
Chitturi S; Farrell GC; Hashimoto E; Saibara T; Lau GK; Sollano JD;
J Gastroenterol Hepatol; 2007 Jun; 22(6):778-87. PubMed ID: 17565630
[TBL] [Abstract][Full Text] [Related]
4. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary.
Farrell GC; Chitturi S; Lau GK; Sollano JD;
J Gastroenterol Hepatol; 2007 Jun; 22(6):775-7. PubMed ID: 17565629
[No Abstract] [Full Text] [Related]
5. How should we manage patients with non-alcoholic fatty liver disease in 2007?
Chan HL; de Silva HJ; Leung NW; Lim SG; Farrell GC;
J Gastroenterol Hepatol; 2007 Jun; 22(6):801-8. PubMed ID: 17565632
[TBL] [Abstract][Full Text] [Related]
6. Non-alcoholic steatohepatitis in the Asia-Pacific region: future shock?
Chitturi S; Farrell GC; George J
J Gastroenterol Hepatol; 2004 Apr; 19(4):368-74. PubMed ID: 15012772
[TBL] [Abstract][Full Text] [Related]
7. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.
Vernon G; Baranova A; Younossi ZM
Aliment Pharmacol Ther; 2011 Aug; 34(3):274-85. PubMed ID: 21623852
[TBL] [Abstract][Full Text] [Related]
8. [Current trends of NASH/NAFLD in Asia-Pacific region].
Ishii H
Nihon Rinsho; 2006 Jun; 64(6):1017-9. PubMed ID: 16768103
[TBL] [Abstract][Full Text] [Related]
9. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
Streba LA; Vere CC; Rogoveanu I; Streba CT
World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population.
Dassanayake AS; Kasturiratne A; Rajindrajith S; Kalubowila U; Chakrawarthi S; De Silva AP; Makaya M; Mizoue T; Kato N; Wickremasinghe AR; de Silva HJ
J Gastroenterol Hepatol; 2009 Jul; 24(7):1284-8. PubMed ID: 19476560
[TBL] [Abstract][Full Text] [Related]
11. The central role of the non alcoholic fatty liver disease in metabolic syndrome.
Hurjui DM; Niţă O; Graur LI; Mihalache L; Popescu DS; Graur M
Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):425-31. PubMed ID: 23077931
[TBL] [Abstract][Full Text] [Related]
12. Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis.
Leoni S; Tovoli F; Napoli L; Serio I; Ferri S; Bolondi L
World J Gastroenterol; 2018 Aug; 24(30):3361-3373. PubMed ID: 30122876
[TBL] [Abstract][Full Text] [Related]
13. Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT).
Kalra S; Vithalani M; Gulati G; Kulkarni CM; Kadam Y; Pallivathukkal J; Das B; Sahay R; Modi KD
J Assoc Physicians India; 2013 Jul; 61(7):448-53. PubMed ID: 24772746
[TBL] [Abstract][Full Text] [Related]
14. Non-alcoholic fatty liver disease guidelines: an Asian perspective.
Ishii H; Kajihara M
J Gastroenterol Hepatol; 2007 Jun; 22(6):769-70. PubMed ID: 17565626
[No Abstract] [Full Text] [Related]
15. [Non-alcoholic fatty liver disease (NAFLD) in patients with metabolic syndrome and type 2 diabetes mellitus. Pathomechanism, new diagnostic markers].
Kieć-Wilk B; Klupa T; Dembińska-Kieć A
Przegl Lek; 2010; 67(7):496-501. PubMed ID: 21387764
[TBL] [Abstract][Full Text] [Related]
16. Are we ready for a new epidemic of under recognized liver disease in South Asia especially in Pakistan? Non alcoholic fatty liver disease.
Parkash O; Hamid S
J Pak Med Assoc; 2013 Jan; 63(1):95-9. PubMed ID: 23865141
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of non-alcoholic fatty liver disease in China.
Fan JG; Farrell GC
J Hepatol; 2009 Jan; 50(1):204-10. PubMed ID: 19014878
[TBL] [Abstract][Full Text] [Related]
18. The epidemiology, pathogenesis and histopathology of fatty liver disease.
Levene AP; Goldin RD
Histopathology; 2012 Aug; 61(2):141-52. PubMed ID: 22372457
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal complications of obesity: non-alcoholic fatty liver disease (NAFLD) and its sequelae.
Karlas T; Wiegand J; Berg T
Best Pract Res Clin Endocrinol Metab; 2013 Apr; 27(2):195-208. PubMed ID: 23731881
[TBL] [Abstract][Full Text] [Related]
20. [Frequency of NAFLD in a group of patients with metabolic syndrome in Veracruz, Mexico].
Roesch-Dietlen F; Dorantes-Cuéllar A; Carrillo-Toledo MG; Martínez-Sibaja C; Rojas-Carrera S; Bonilla-Rojas QC; Uchino-Higueras V; Lagunas T; Carrasco-Arróniz MA; Soler-Leal B; León-Valdivieso J; Cid-Juárez S; Martínez JA
Rev Gastroenterol Mex; 2006; 71(4):446-52. PubMed ID: 17542277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
